4.6 Article

Salvia miltiorrhiza: Traditional medicinal uses, chemistry, and pharmacology

Journal

CHINESE JOURNAL OF NATURAL MEDICINES
Volume 13, Issue 3, Pages 163-182

Publisher

CHINESE JOURNAL NATURAL MEDICINES
DOI: 10.1016/S1875-5364(15)30002-9

Keywords

Danshen; Cardiovascular diseases; Antitumor; Side effect; Review

Funding

  1. Young Scientist Special Project of the National High Technology Research and Development Program of China [2014AA020508]
  2. National Nature Science Foundation of China [81473301]

Ask authors/readers for more resources

Salvia miltiorrhiza Bunge (SM) is a very popular medicinal plant that has been extensively applied for many years to treat various diseases, especially coronary heart diseases and cerebrovascular diseases, either alone or in combination with other Chinese plant-based medicines. Although a large number of studies on SM have been performed, they are scattered across a variety of publications. The present review is an up-to-date summary of the published scientific information about the traditional uses, chemical constituents, pharmacological effects, side effects, and drug interactions with SM, in order to lay the foundation for further investigations and better utilization of SM. SM contains diverse chemical components including diterpenoid quinones, hydrophilic phenolic acids, and essential oils. Many pharmacological studies have been done on SM during the last 30 years, focusing on the cardiovascular and cerebrovascular effects, and the antioxidative, neuroprotective, antifibrotic, anti-inflammatory, and antineoplastic activities. The research results strongly support the notion that SM has beneficial therapeutic properties and has a potential of being an effective adaptogenic remedy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available